ABSTRACT
Coronavirus disease (COVID-19) has affected millions of people across the WHO European Region. While the acute phase of the pandemic has passed, it is estimated that 10–20% of those infected with SARS-CoV-2 continue to have symptoms long after their initial illness. Using a tool devised by WHO for collecting data on the management of the post COVID-19 condition (PCC), also known as long COVID, three countries – Israel, Italy and the United Kingdom – and two autonomous regions of Spain – Aragon and Catalonia – collated detailed descriptions of service delivery models that support patients with PCC. This report synthesizes findings from those countries and regions, showing differences and similarities, and concludes with suggestions as to how other health systems can adjust their services to better meet the needs of patients with this debilitating condition.
Subject(s)
COVID-19 , Prevalence , Health Services , EuropeABSTRACT
This report provides an overview of the latest tuberculosis (TB) epidemiological situation and is published jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control. In 2022, a little over 170 000 incident TB cases were notified in countries of the WHO European Region, a slight increase from 2021. The increase in 2022 is likely due to a good recovery after the COVID-19 pandemic in access to and provision of TB services in many countries and the introduction of active TB case-finding activities. Despite the notable progress achieved in the fight against TB, countries still face various challenges in reaching the goal of ending the TB epidemic in the WHO European Region. Monitoring progress towards the targets of the new Tuberculosis action plan for the WHO European Region 2023–2030 is difficult due to limited or no reporting on some indicators. Further improvement of data completeness and representativeness should be the focus for all countries.
